UPI Study › Courses › Ethics in Technology › Free lessons › Lesson 14.3 Free with a free account
Where Biology Meets Technology — The Science of Modifying Living Systems for Human Benefit
Ethics in Technology · Chapter 14: Tomorrow's Technology: AI, Biotech, IoT, and the Connected FutureSection 14.3 · lesson 91 of 11615 min · free with a free account
Free preview
Create a free account to keep watching
It takes a minute and costs nothing. Your free account unlocks all of Chapter 1 and 3 more lessons of Ethics in Technology.
Lesson complete
Earn the 3 college credits for Ethics in Technology
Enrolling adds a quiz after each lesson, the graded work and the official transcript. Recommended for credit by NCCRS.
Next lesson: The Core Ideas Behind Connecting Everyday Physical Objects to the Internet →← How Machines That Simulate Human Thinking Are Changing Every Industry — Artificial Intelligence, Machine Learning, Deep Learning, and Generative AINext lesson: The Core Ideas Behind Connecting Everyday Physical Objects to the Internet →
In this lesson
Living systems, targeted DNA changes, and the choices surrounding their use.
- Distinguish traditional biotechnology from modern DNA-based methods.
- Explain guide RNA, Cas9 cutting, and cellular repair.
- Identify GMOs and biotechnology applications in medicine and agriculture.
- Analyze safety, heritable changes, enhancement, consent, and equitable access.
Free study notes
Get this lesson's notes by email
The key points and 4 practice questions with answers, in your inbox. One email, free.
One email. Unsubscribe in one click.
Transcript
Everything said in the video, section by section (1,682 words). Read along, or search it.
Tomorrow's Technology: AI, Biotech, IoT, and the Connected Future
Where Biology Meets Technology
Biotechnology uses living organisms, or parts of them, to develop useful products and processes. Its history includes fermentation and selective breeding, long before people understood the structure of DNA. Modern methods add tools for reading, copying, and directly changing specific genetic material. We will examine genetic engineering, then follow the guide-and-cut approach commonly called CRISPR-Cas9. A guide RNA helps locate a target, while an enzyme makes the cut that permits repair. Cellular repair then influences the resulting change, so targeting alone does not guarantee a perfect outcome. Applications include engineered crops and bacteria producing medicines. Other uses include therapies, diagnostics, and agricultural improvements. Those benefits raise questions about safety, inherited changes, consent, enhancement, and access to expensive treatments. By the end, connect the biological mechanism with the people and environments affected by its use.
A Long History
Biotechnology Uses Living Systems to Produce Useful Results
Traditional biotechnology includes brewing with yeast, whose fermentation helps transform ingredients into a different product. Bacterial cultures used in cheese-making provide another familiar example of organisms contributing useful properties. Selective breeding favors desired traits in crops and livestock across generations, using inherited variation. These practices existed long before the direct molecular tools associated with modern genetic engineering. DNA carries genetic information, allowing scientists to study sequences linked with biological functions and traits. Modern tools can read or copy that information. Some can also directly manipulate particular sequences. This increases the ability to target changes, rather than relying only on selecting organisms over generations. Conventional breeding still changes inherited traits, so the distinction concerns the method rather than whether genetics matters. Greater targeting power creates useful possibilities, together with questions about consequences that remain difficult to predict.
Direct Genetic Change
CRISPR-Cas9 Supplies a Targeting Tool and a Cutting Enzyme
Genetic engineering directly manipulates DNA to add, remove, or alter material within an organism’s genome. CRISPR-Cas9 combines a targeting component with a cutting enzyme. Together, they create a practical method for directed changes. The guide RNA contains a sequence intended to help recognize the chosen target within the DNA. Cas9 is the enzyme that makes the cut in the guide-and-cut approach described in this lesson. The cell’s own repair processes then act on the cut, influencing which sequence remains afterward. This technology was adapted from microbial defenses that recognize invading genetic material, including viral DNA. Its development made targeted editing faster and more practical than many earlier approaches to particular changes. However, improvements in speed and precision do not remove every limitation or unintended biological consequence. Understand the separate roles of targeting, cutting, and repair before considering the broader applications.
Five Linked Stages
A Targeted Cut Is Followed by Biological Repair
The diagram separates the mechanism into five stages, beginning with a guide designed for a target. Matching helps direct the guide-and-enzyme complex toward the intended DNA location within the cell. Cas9 then cuts both DNA strands in this nuclease approach, making a localized change possible. The cell recognizes that damage and activates its own biological machinery to repair the affected DNA. One repair outcome can disrupt the targeted gene, changing its normal function in the edited cell. Under suitable conditions, repair can instead incorporate a sequence supplied for the intended change. The resulting DNA must be examined. A targeted cut is not the same as a guaranteed replacement. Cutting is therefore part of the genome-editing process, rather than the whole explanation of its final result. The repair stage links the molecular scissors analogy with the actual biological change that researchers seek.
The Analogy and Its Limit
DNA Repair Is More Complex Than Find and Replace
A word processor’s find-and-replace feature provides a useful first analogy for targeting a genetic sequence. The guide helps find the intended region, and cutting creates an opportunity to change what remains. Unlike typed text, however, DNA is processed through biological recognition and repair pathways with variable outcomes. A cut does not simply paste the requested replacement into every targeted cell with perfect reliability. Unintended changes can occur. Not every cell necessarily acquires the same desired edit. Researchers must therefore evaluate the resulting sequence and biological effects, rather than rely only on the targeting plan. This lesson describes the guide-and-cut Cas9 approach; genome editing also includes techniques with different mechanisms. The central point is that greater precision improves possibilities without making the organism behave like an editable document. That limit matters especially when changes affect a patient, an environment, or possible future generations.
What GMO Means
Engineered Organisms Extend Beyond Familiar Crops
A genetically modified organism has had its genetic material altered through genetic engineering methods. The distinction here contrasts direct engineering with ordinary mating or conventional selective breeding alone. Regulatory definitions can differ, so this broad educational distinction should not be treated as a universal legal test. Familiar examples include corn, soybeans, and cotton engineered for pest resistance or herbicide tolerance. Other crop projects seek nutritional changes, linking biotechnology with the composition of foods people consume. Engineered bacteria also manufacture insulin and other therapeutic proteins, showing that GMOs extend beyond agriculture. The intended trait matters when evaluating a product. Organisms made through similar methods can differ substantially. A crop engineered for a particular pest is not automatically protected against every disease or environmental stress. Examine the specific genetic change, purpose, and context, rather than assuming the GMO label explains every consequence.
Medical Applications
Biotechnology Supports Manufacturing, Treatment, and Diagnosis
In medicine, engineered cells can produce insulin and other therapeutic proteins at manufacturing scale. These products use living systems to generate useful biological substances with defined medical purposes. Gene therapies seek to address inherited disorders by changing or supplying genetic information relevant to treatment. Different gene therapies have different mechanisms. Gene therapy should not be treated as identical to every editing method. Biotechnology also supports vaccine design, helping researchers develop and evaluate ways to protect against disease. Molecular diagnostic tests analyze biological material with specificity that can support identification of important features. These applications illustrate useful contributions across manufacturing, treatment, prevention, and the assessment of health conditions. A promising mechanism still needs evidence about risks, effectiveness, and appropriate delivery for the proposed use. Neither the biotechnology label nor a targeted mechanism guarantees approval or suitability for every patient.
Agricultural Applications
Desired Traits Address Different Food and Farming Problems
Agricultural biotechnology seeks traits that address particular causes of crop loss or food-production problems. Pest-resistant and drought-related crop designs aim to improve performance under conditions relevant to those traits. Nutritional projects can include rice designed for vitamin-related benefits, connecting genetic changes with dietary goals. Other work aims to extend usable shelf life, reducing losses from spoilage or deteriorating produce quality. Livestock programs can seek disease resistance through breeding or engineered traits, depending on the particular approach. These are different applications, rather than a single promise that one modification solves all agricultural challenges. The organism’s performance must be assessed within its actual environment. Evaluation also considers the farming practices used there. Effects on other organisms, and possible movement of genetic material, also require attention during evaluation. Potential agricultural benefits therefore belong alongside case-specific evidence about safety, ecological consequences, and practical conditions.
Food and Environmental Safety
Assess the Actual Product Rather Than Assuming All GMOs Are Identical
Food safety debates often raise concern about possible long-term effects from consuming genetically engineered products. FDA describes marketed GMO foods as no less safe than comparable foods without genetic engineering. Food products must meet applicable safety standards, with evaluation addressing the particular product and its characteristics. That assessment does not imply that every future genetic change should receive the same conclusion automatically. Environmental questions include possible movement of engineered traits into wild populations and the consequences of that movement. Those effects depend on the organism, trait, location, and ecological relationships, rather than the method label alone. A conclusion about food safety does not settle every question. Environmental impact and agricultural practice also require evaluation. The strongest discussion separates the concerns and examines relevant evidence for each, instead of treating all GMOs identically. Continuing case-by-case evaluation can recognize established benefits while investigating uncertainties associated with new applications.
Heritable Changes
Germline Editing Raises Questions beyond One Patient
Somatic treatment changes targeted body cells in a patient, with benefit and risk assessed for that person. Heritable editing concerns changes to reproductive cells or embryos that may pass to future generations. That difference extends the consequences beyond the individual immediately involved in the procedure or decision. Future descendants cannot provide consent to an inherited change. The decision is made in an earlier generation. Proponents emphasize the possibility of preventing inherited disease and avoiding suffering before it begins. Critics emphasize safety uncertainty, unintended consequences, and the difficulty of assessing effects across generations. Potential disease prevention is not a guarantee that every condition can be permanently eliminated from a family. The ethical comparison should specifically distinguish somatic treatment from heritable changes, rather than simply adult from embryo. Consent, evidence, and intergenerational consequences remain central to evaluating the different purposes of genome editing.
Enhancement and Access
Boundaries and Affordability Require Deliberate Choices
The designer-baby debate concerns moving from treating disease toward changing preferred appearance, abilities, or other non-medical traits. Critics worry that enhancement could deepen social inequality and reinforce pressure to meet particular expectations. Proponents respond by distinguishing treatment from enhancement and arguing that accountable limits should guide use. The boundary between treatment and enhancement can be contested. Regulations differ rather than following one clear global rule. Access raises another concern: expensive interventions may concentrate benefits among wealthier patients or countries. Advocates hope that development and scaling can lower costs and widen availability over time. Such changes are possible, but lower prices or fair access are not automatic outcomes of technical progress. Policies and practical delivery conditions influence who can benefit, alongside whether a treatment works biologically. A tool’s usefulness does not settle its ethics without examining how it is applied and distributed.
Review and Apply
Connect the Biological Mechanism with Its Human Consequences
For the first review question, distinguish direct DNA tools from older fermentation and selective breeding practices. The modern methods add molecular analysis and manipulation, rather than making earlier biotechnology cease to exist. For the second, identify the guide RNA’s targeting role and Cas9’s cutting role in this approach. For the third, explain that cellular repair completes the sequence change. Those outcomes still need evaluation. For the fourth, contrast direct genetic engineering with ordinary mating or conventional selection across generations. For the fifth, connect germline editing with changes that may be inherited by descendants unable to consent. Somatic treatment instead targets the patient’s body cells, with the assessment centered on that person’s treatment. Compare medical and agricultural benefits with safety, ecological consequences, consent, enhancement, and equitable access. A thoughtful evaluation explains both the possible gains and who bears the uncertainties or receives a voice.
About Ethics in Technology at UPI Study
Ethics in Technology (Computer Science 195) is a self-paced online course of 116 video lessons in 15 chapters, from cybersecurity basics, privacy and surveillance to big data, hacking, malware, network defense, intellectual property, cybercrime, encryption, emerging technology and digital citizenship. It carries a NCCRS credit recommendation for 3 semester credits.
Every lesson transcript is free on pages like this one, and the videos are free with a free UPI Study account. Enrolling adds a practice quiz after each lesson, the graded work and final exam that earn the credit, lifetime access, and an official transcript on completion. UPI Study has helped over 130,000 students with college credits. ACE and NCCRS have over 2,100 cooperating colleges that will consider accepting credits; the final decision is with the universities.
Enroll now → Course details Download the syllabus All Computer Science courses
Compare: Cybersecurity vs Ethics in Technology · Which ethics course?
Why take it here
Why students take Ethics in Technology with UPI Study
Where the credit goes
Universities that work with NCCRS
Ethics in Technology carries a NCCRS credit recommendation. These universities work with NCCRS; some are UPI Study's signed partners. ACE and NCCRS have over 2,100 cooperating colleges that will consider accepting credits; the final decision is with the universities.
Thomas Edison State UniversitySigned partner
University of the PeopleSigned partner
Charter Oak State CollegeSigned partner
Strayer UniversitySigned partner
Columbia Southern UniversitySigned partner
Indiana TechSigned partner
Penn StateWorks with NCCRS
Southern New Hampshire UniversityWorks with NCCRS
SUNYWorks with NCCRS
+many more cooperating universitiesFind my college →Find my college → Not listed? Ask Athena in the corner of this page, or book a 15-minute call.
FAQ
Questions students ask us
About Where Biology Meets Technology — The Science of Modifying Living Systems for Human Benefit
How does CRISPR-Cas9 gene editing work?
What is a GMO, and are GMO foods safe to eat?
What is the difference between somatic and germline gene editing?
What is the designer baby debate?
About the Ethics in Technology course
How many college credits is Ethics in Technology?
How much does Ethics in Technology cost and what is included?
Which universities accept UPI Study credits?
How long does Ethics in Technology take?
How are the exams done?
How do my credits reach my college?
Ready for the full course? Earn 3 credits in Ethics in Technology.
116 video lessons, a quiz after each one, and the graded work that earns the credit. Recommended for credit by NCCRS.
3 credits · NCCRSEnroll →